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Abstract
Background: The inhibitory effect of andrographolide sodium bisulphite (ASB) on jack bean urease (JBU) and
Helicobacter pylori urease (HPU) was performed to elucidate the inhibitory potency, kinetics and mechanism of
inhibition in 20 mM phosphate buffer, pH 7.0, 2 mM EDTA, 25 °C.
Methods: The ammonia formations, indicator of urease activity, were examined using modified spectrophotometric
Berthelot (phenol-hypochlorite) method. The inhibitory effect of ASB was characterized with IC50 values.
Lineweaver-Burk and Dixon plots for JBU inhibition of ASB was constructed from the kinetic data. SH-blocking
reagents and competitive active site Ni2+ binding inhibitors were employed for mechanism study. Molecular
docking technique was used to provide some information on binding conformations as well as confirm the
inhibition mode.
Results: The IC50 of ASB against JBU and HPU was 3.28 ± 0.13 mM and 3.17 ± 0.34 mM, respectively. The inhibition
proved to be competitive and concentration- dependent in a slow-binding progress. The rapid formation of initial
ASB-JBU complex with an inhibition constant of Ki = 2.86 × 10
−3 mM was followed by a slow isomerization into the
final complex with an overall inhibition constant of Ki* = 1.33 × 10
−4 mM. The protective experiment proved that
the urease active site is involved in the binding of ASB. Thiol reagents (L-cysteine and dithiothreithol) strongly
protect the enzyme from the loss of enzymatic activity, while boric acid and fluoride show weaker protection,
indicating that the active-site sulfhydryl group of JBU was potentially involved in the blocking process. Moreover,
inhibition of ASB proved to be reversible since ASB-inactivated JBU could be reactivated by dithiothreitol application.
Molecular docking assay suggested that ASB made contacts with the important sulfhydryl group Cys-592 residue and
restricted the mobility of the active-site flap.
Conclusions: ASB was a competitive inhibitor targeting thiol groups of urease in a slow-binding manner both
reversibly and concentration-dependently, serving as a promising urease inhibitor for the treatment of urease-related
diseases.
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Background
Urease (urea amidohydrolase, EC 3.5.1.5) which cata-
lyzes the hydrolysis of urea to produce ammonia and
carbon dioxide has been found in plants, algae, fungi,
bacteria and soil [1]. It is a thiol-rich and nickel-
dependent metalloenzyme that can catalyze the hydroly-
sis of urea, thereby producing ammonia and carbamate
[2]. In addition to the archetypical nickel-containing ure-
ase, Helicobacter mustelae, a gastric pathogen of ferrets,
was recently found to synthesize a distinct iron-
dependent oxygen-labile urease with dinuclear Fe and
less activity [3]. Nevertheless, the nickel ions (Ni2+) and
the sulfhydryl group, especially the multiple cysteinyl
residues in the active site of the enzyme, are essential for
the catalytic activity of all ureases. As the reaction re-
sults in the increase of pH values, urease is responsible
for negative effects of urease activity in human health
and agriculture.
Helicobacter pylori (H. pylori) is a well-established
etiologic agent of gastritis, gastric and duodenal ulcer-
ation, even gastric carcinoma [4]. H. pylori urease
(HPU), a highly active urease produced by H. pylori, is a
virulence factor in infections of gastrointestinal tracts.
HPU could initiate the hydrolysis of urea generating am-
monia, which allows the bacterium to survive and
colonize the low pH environment of the gastric mucosa
[5]. Therefore, strategies based on urease inhibition are
now considered as the first line of treatment for infec-
tions caused by urease-producing microorganisms.
In past decades, varieties of urease inhibitors have
been investigated including phosphoramidates [2],
hydroxamic acids [6], boric and boronic acids [7], heavy
metal ions [8], quinones [9] and imidazoles [10]. How-
ever, most of these compounds are too toxic or unstable
to be therapeutic agents. Thus, current researches are
focused on finding novel urease inhibitors with promis-
ing levels of activity from natural plant.
Andrographolide (C20H30O5), the major diterpenoid
lactone and the primary effective constituent of Andro-
graphis paniculata (a widely used Chinese medicinal
herb known as ‘Chuan-Xin-Lian’ in Chinese), has mul-
tiple pharmacological properties, including antimicrobial
[11], anti-inflammation [12, 13], anti–cancer [14] and
immunity enhancement [15–17]. Andrographis panicu-
lata was reported to posses anti-H. pylori activity [18]
and effectively relieve H. pylori associated gastritis in
clinical practice [19, 20]. In addition, a variety of andro-
grapholide derivatives proved to exert inhibitory effects
on enzymes [21–23]. Therefore, andrographolide is ex-
pected to exert inhibitory properties against urease, coun-
teracting the undesirable effects brought about by activated
urease. Jack bean urease (JBU) is the best-characterized
[24–26] and widely-employed instrumental enzyme in ure-
ase inhibition research [27, 28]. Additionally, it has been
found that the inhibition mechanism of action and kin-
etics of inhibition for bacteria urease and JBU are simi-
lar [29]. In the present investigation, the inhibitory
effect against JBU of andrographolide sodium bisulphite
(ASB, C20H29O7S · Na, shown in Fig. 1), a water-soluble
sulfonate of andrographolide, was performed to eluci-
date the kinetics and mechanism of inhibition.
Methods
Materials and reagents
Andrographolide sodium bisulfite (C20H29O7S · Na, CAS
number 71202-97-6), urea (molecular biology reagent),
D,L-dithiothreitol (DTT) , L-cysteine (L-cys), boric acid
and sodium fluoride (NaF) were purchased from Sigma
Aldrich. JBU (from jack bean, Canavalia ensiformis, type
III, nominal activity 40.3 units/mg, solid) was also from
Sigma Aldrich, of which one unit of urease activity is de-
fined as the amount of enzyme needed to liberate
1.0 μmol of NH3 from urea per min at pH 7.0 at 25 °C.
Brucella broth was purchased from Becton–Dickinson.
(Cockeysville, MD). Other chemicals were obtained from
Guangzhou Chemical Reagent Factory (China). All re-
agents were of analytical grade. Phosphate buffer (PBS,
20 mM, pH 7.0) was prepared by adjusting pH of phos-
phoric acid with NaOH. 2 mM EDTA was added to all
enzyme-containing solutions.
Preparation of H. pylori urease
Helicobacter pylori (ATCC 43504; American Type Cul-
ture Collection, Manassas, VA) was grown in brucella
broth supplemented with 10 % heat-inactivated horse
Fig. 1 Chemical structure of ASB
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serum for 24 h at 37 °C under microaerobic conditions
(5 % O2, 10 % CO2, and 85 % N2) [30, 31]. For urease in-
hibition assays, 50 ml broth cultures (2.0 × 108 CFU/mL)
were centrifuged (5000 g, 4 °C) to collect the bacteria,
and after washing twice with phosphate-buffered saline
(pH 7.4), the H. pylori precipitation was stored at -80 °C.
H. pylori was returned to room temperature, and after
addition of 3 mL of distilled water and protease inhibi-
tors, sonication was performed for 60 s. Following cen-
trifugation (15,000 g, 4 °C), the supernatant was desalted
through Sephadex G-25 column (PD-10 columns,
Amersham–Pharmacia Biotech, Uppsala, Sweden). The
resultant crude urease solution was added to an equal
volume of glycerol and stored at 4 °C until use in the
experiment.
Standard urease activity assay
The standard urease assay mixture contained 50 mM
urea in 20 mM phosphate buffer (pH 7.0) containing
2 mM EDTA. After addition of the enzyme-containing
solution of 0.25 mg/mL JBU, the assay ran for 20 min,
and the enzyme activity was determined by measuring
the concentration of the ammonia released in the reac-
tion mixture. For ammonia measurement, aliquots were
withdrawn from the reaction mixtures, and the ammonia
was determined at 595 nm spectrophotometrically ac-
cording to the modified Berthelot (phenol-hypochlorite)
method [32] at ambient temperature.
Inactivation of JBU by ASB
Urease solutions mixed with serial concentrations of
ASB ( 0–6 mM) were incubated at 37 °C for 20 min,
which contained 0.25 mg/mL JBU, 20 mM phosphate
buffer (pH 7.0), and 2 mM EDTA. The initial time of in-
cubation was defined as the moment once the enzyme
and inhibitor were mixed. After appropriate period of
time, aliquots from the incubation mixture were trans-
ferred into the standard assay mixtures for urease re-
sidual activity determination. The activity of uninhibited
urease was defined as the control activity of 100 %.
Determination of KM and vmax
The Michaelis constant KM and the maximum velocity
vmax in the absence of the inhibitor were determined by
measuring the initial reaction velocities at different urea
concentrations ranging from 0.4 to 10 mM. The values
were obtained by applying nonlinear regression to the
Michaelis-Menten equation.
Reaction progress curves monitoring
The reaction progress was studied in the absence or
presence of ASB using the following two procedures.
(a)Unpreincubated System. The progress curves were
determined by the reactions directly initiated by the
addition of the JBU into the reaction mixtures
containing different concentrations of ASB (2, 4 and
6 mM).
(b)Preincubated System. The JBU was preincubated
with ASB for 20 min first, and the reaction was then
initiated by addition of urea solution into the
reaction preincubation mixtures containing different
concentrations of ASB (2, 4 and 6 m.M).
JBU activities in both procedures were determined as
described in standard urease activity assay. A curve-
fitting computer program was employed to fit the ex-
perimental points to the integrated equation describing
slow-binding inhibition progress curves [7]:





where p is the amount of product accumulated at time t
after initiation of the reaction. v0 and vs are the reaction
initial and steady-state velocities, respectively, and kapp
denotes the apparent first-order velocity constant for
interconversion between v0 and vs.
JBU protection against ASB inactivation
This part of the study was carried out as follows. JBU
was first preincubated with different protectors for
20 min. Then, samples of the protected JBU were incu-
bated with 4 mM ASB for additional 20 min. The urease
activity was assayed upon incubation of the mixture. For
protection by boric acid and NaF, JBU was preincubated
with 4 mM boric acid and 4 mM NaF, respectively. For
protection by thiols, the applied thiol-containing com-
pounds (L-cys and DTT) were of a series of
concentrations.
ASB -thiol-urease interaction test
The incubation mixtures contained JBU solution, ASB,
and mono thiols (L-cys) or dithiol (DTT). The compo-
nents of the incubation mixture were mixed according
to the following three procedures:
(a) JBU was added to the mixture after a 20 min
contact of ASB with the thiol.
(b)ASB was added to the mixture after a 20 min
contact of JBU with thiol.
(c)Thiol was added to the mixture after a 20 min
contact of JBU with ASB.
The complete mixture was mixed thoroughly and in-
cubated for additional 5, 10, 20, and 40 min. Then, JBU
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activity assay was determined as described in the inacti-
vation of JBU by ASB.
Reactivation of ASB -inactivated JBU
The reactivation of inactivated JBU was studied in two
ways: by using DTT, L-cys and by multidilution in the
reaction mixture containing urea.
(a)After a 20 min preincubation of JBU with ASB
(4 mM), the mixture was further incubated with
DTT or L-cys for 120 min. The activity of JBU
was determined before and after the addition
of DTT.
(b)ASB (4 mM) was preincubated for 10 and 20 min,
respectively, with the enzyme to establish the
equilibrium: E + I ⇔ EI ⇔ EI ∗, and then the
preincubation mixture was diluted 50 folds into the
reaction mixture. After appropriate period of time,
aliquots were withdrawn, and the amount of ammonia
was determined.
Molecular docking
The automated docking studies were carried out using
Auto-Dock version 4.0 as implemented through the
graphical user interface AutoDock Tools (ADT 1.5.2).
The three-dimensional crystal structure of JBU (PDB
code: 3LA4) was obtained from the RCSB Protein Data
Bank,whose resolution was 2.05 Å . The required ac-
tions were to remove water molecules from the pro-
tein, add all hydrogen atoms, calculate Gasteiger
charges, and merge nonpolar hydrogen atoms to car-
bon atoms. The standard 3D structure (PDB format) of
ASB was obtained with chem3D Ultra 8.0 software.
The PDB files were further transferred to PDBQT files
with AutoDock Tools. The three-dimensional results were
created by the PyMol molecular graphics system [33]. The
cubic grid box of 60 Å size (x, y, z ) with a spacing of
0.5 Å and grid maps were built. The center of the grid
was set to the average coordinates of the two Ni2+
ions. The Lamarckian genetic algorithm (LGA) was
selected as the search algorithm. The Lamarckian job
consisted of 100 runs. Default settings were used with
an initial population of 150 randomly placed
individuals, a maximum number of 2.5 × 106 energy
evaluations, and a maximum number of 2.7 × 104 gen-
erations. A mutation rate of 0.02 and a crossover rate
of 0.8 were chosen. Van der Waals and hydrogen
bonding were included in the calculated non-bonded
energy. Results differing by less than 0.5 Å in pos-
itional root-mean-square deviation (RMSD) were clus-
tered together, and the results of the most favorable




The system of jack bean urease-ASB-urea, can be treated
as a model system in the studies on the utility of ASB in
the therapy of diseases caused by H. pylori and other
bacteria producing urease. Data from Fig. 2 depicted
urease residual activity as a function of ASB concentra-
tion. The IC50 indicated the ASB concentration that
could descend the activity of urease to 50 %. The ob-
tained IC50 value of ASB against HPU and JBU was
3.17 ± 0.34 mM (R2 = 0.976) and 3.28 ± 0.13 mM (R2 =
0.997), respectively. The linear function for this relation
was a good-enough approximation. Based on the above
mentioned, a conclusion could be drawn that ASB per-
formed similar effectiveness on the inhibition of these
two ureases.
Kinetics of JBU inactivation by ASB
Enzyme kinetics was determined in the absence and pres-
ence of various concentrations of ASB. KM and vmax of
ureolytic reaction by applying nonlinear regression to the
Michaelis-Menten equation were 2.001 ± 0.08 mM and
0.125 ± 0.07 mM/min, respectively. As the Lineweaver-
Fig. 2 Dependence of residual activity versus concentration of ASB.
a residual activity of JBU inhibited by ASB; b residual activity of HPU
inhibited by ASB
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Burk plots for ASB shown in Fig. 3, KM value did not sig-
nificantly change in the presence of ASB, while the Vmax
value decreased as the ASB concentration increased, indi-
cating that the effect of ASB on JBU might be a noncom-
petitive mechanism of inhibition. Additionally, our data
indicated a slow-binding inhibition relationship of enzyme
activity versus preincubation time [9, 34], which indicated
the total urease activity in the free form and in the form of
being bound in the urease inhibitor complexes EI and EI*.
It was clear in Fig. 4 that increasing the preincubation
time resulted in a decrease of urease activity. The activity
descended rapidly at the beginning until the equilibrium
between urease (E), inhibitor (I), and urease-inhibitor
complexes (EI) and (EI*) (E + I ⇔ EI ⇔ EI* ) was achieved,
which was characterized by the constant urease activity,
since the slow-binding effect would not be revealed unless
the enzyme interacted with the inhibitor for sufficient
time. Otherwise, it would lead to a misinterpretation as a
noncompetitive type if determined by the initial reaction
rates method. Hence, the progress curves analysis was
employed to confirm the slow-binding model of JBU in-
activation by ASB.
Progress curves analysis
The progress curves for urea hydrolysis under ASB-
inhibited JBU catalyzation were shown in Fig. 5. The re-
action progress curves for the unpreincubated system
were concave downward (Fig. 5(a)), indicating that the
velocity of urea hydrolysis decreased from an initial vel-
ocity (v0) to a much slower steady-state velocity (vs) ac-
cording to the apparent first-order velocity constant
kapp. Such a behavior is characteristic of slow-binding in-
hibition elaborated by the theory of Morrison and
Walsh. The obtained results also showed that the v0 and
vs were inhibitor concentration-dependent. In terms of
the preincubation system (steady-state analysis, Fig. 5(b)),
the linear curves proved that the reaction achieved the
Fig. 3 Lineweaver-Burk plot of the reciprocal of urease activity
versus reciprocal of substrate concentration in the absence and
presence of 2 mM, 4 mM, and 6 mM of ASB
Fig. 4 Dependence of residual activity versus preincubation time
with ASB. Concentration of ASB (mM) is numerically given
Fig. 5 a Reaction progress curves of urease-catalyzed hydrolysis of
urea in the presence of ASB; b Steady-state analysis: concentration of
ammonia versus time. ASB concentration (mM) is numerically given
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steady-state velocity (vs), being different from each stud-
ied inhibitor concentration.
The obtained relationship of the reaction velocities (v0;
vs) versus the inhibitor concentration is characteristic of















where E is enzyme, S is substrate, P is product, I is in-
hibitor, and EI and EI* are enzyme-inhibitor complexes,
respectively. k1-k7 are velocity constants. Linear depend-
encies of 1/v0 and 1/vs on the inhibitor concentration



























where KM is the Michaelis constant and vmax is the max-
imum velocity given by the Michaelis-Menten equation
for the uninhibited reaction; S0 denotes the initial concen-
tration of urea; Ki and Ki* are the inhibition constants de-
fined as: Ki = [E] [I] / [EI] and Ki* = [E] [I] / ( [EI] + [EI*] )
respectively.
By calculating from reciprocal dependence of v0 and vs
on the inhibitor concentration according to formula [3], it
was found that the initial ASB-JBU complex formed rapidly
with an inhibition constant of Ki = (2.86 ± 0.09) × 10
−3 mM,
followed by a slow isomerization into the final ASB-
urease complex with the overall inhibition constant of
Ki* = (1.33 ± 0.11) × 10
−4 mM. The rate constant of the
ASB-JBU isomerization indicated that forward process
was rapid in contrast with slow reverse reactions. The
overall inhibition constant obtained by the steady-state
analysis was (1.18 ± 0.13) × 10−3 mM. Furthermore, the
shape of the curves in that case corresponded to the
competitive slow-binding type of inhibition, as repre-
sented by formula [1]. In details, the reaction was
inhibited slightly in the initial period, characterized by
high reaction rates v0. Then, in the later period, the in-
hibition became stronger, characterized by lower reac-
tion rates vs. This indicated a competitive inhibition in
both initial and steady-state stages of the inhibition
reaction.
Taken together, the progress curves analysis and pre-
incubation studies proved that the ASB inhibition on
urease was indeed in a slow-binding and competitive
manner.
Urease protection against ASB inactivation
Up to now, it has been found that there were two well-
defined urease protectors. One is the inorganic com-
pounds (NaF and boric acid) reacting with active-site
nickel ions, and the other is thiol-containing compounds
such as DTT and L-cys, which interact with sulfhydryl
groups of urease [35, 36]. When equilibrated with the
enzyme, the protectors by occupying the active site re-
strict the accessibility of inhibitions to the active-site
functional groups. Hence, in the present investigation,
both protectors were employed to investigate the pos-
sible inhibition target of ASB. According to Fig. 6(a), the
urease protection effect against inactivation by ASB was
enhanced as the concentration of thiol reagents in-
creased. After the inactivation by 4 mM ASB, L-cys and
DTT could restore the urease activity in a concentration-
dependent manner. This indicated that the thiol groups
were involved in the inactivation of the enzyme and that
there was a better affinity of ASB towards L-cys and DTT
than the thiol group in urease. Meanwhile, the protective
potency of L-cys was found stronger than that of DTT.
This might be due to the pH of the reaction system
Fig. 6 a L-cys and DTT protection of urease against ASB. Concentration
of L-cys and DTT (mM) is numerically given; b Protection of urease
against ASB inactivation by boric acid and sodium fluoride
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(pH = 6.9-7.0), in which DTT failed to exert the desired
protective effect [37]. By contrast, protections with so-
dium fluoride (a competitive slow-binding urease in-
hibitor) [35] and boric acid (a classical competitive
urease inhibitor) [35, 36] were relatively insignificant.
As Fig. 6(b) demonstrated, when urease was inactivated
by ASB in the presence of sodium fluoride and boric
acid, the enzymatic activity decreased to 11.42 % and
15.61 %, respectively, even lower than that in the pres-
ence of ASB alone, suggesting a probable synergic rela-
tionship between ASB and sodium fluoride or boric
acid. Obviously, better prevention by thiols than by in-
organic compounds against ASB inactivation indicated
that the active-site sulfhydryl group might be a residue
responsible for urease inhibition.
ASB-thiol-urease interaction test
The role of thiols in ASB inactivation was studied by
comparing urease activities in thiol-free system at three
time points of incubation. It was found that monothiol
(L-cys) and dithiol (DTT) could alleviate the inactivation
by ASB, and urease regained activity in spite of ASB
presenting in the incubation mixture. When the thiol-
containing compounds provided thiol groups, concen-
tration was equal or higher than that of ASB. However,
as Fig. 7(a and b) shown, incubation time had no signifi-
cant effect on the ASB-thiol-urease interaction. And the
protection potency remained consistent regardless of the
addition order of urease, inhibitors, and protectors.
The presence of the thiol-protector in the incubation
system allowed ASB to react with thiols from the JBU
and those in the “free” thiol-protector. The thiols pre-
senting in the protein were much less reactive than
those presenting externally in the form of L-cys or DTT.
The decreases of urease activity in the thiol-free system
and system with the thiols were compared, suggesting
that the general losses of urease activity in both systems
remained, but it was slowed down in the presence of
thiols, especially in the presence of L-cys. These data
suggested that ASB-thiol interaction was strategic for
the inactivation rate decrease.
Reactivation of ASB-inactivated urease
To investigate whether the inactivation of JBU by ASB
was reversible, the reactivation of ASB-inactivated JBU
was carried out in two ways. In the first way, by addition
of L-cys or DTT after the 20 min incubation of JBU with
ASB, urease activity recovered in a time-dependent man-
ner: after 1.5 h, JBU had restored 90.77 % and 70.98 % of
its initial activity, respectively (Fig. 8). After reactivated
by L-cys or DTT, retreatment of ASB could not inhibit
the urease activity again. This evidence indicated that
the urease-ASB complex was less resistant for chemical
approach.
Fig. 7 a Thiol influence on urease inactivation by ASB relative to the
control activity. The percent of the enzyme activity in the presence
of ASB without the thiol is given as comparison. Concentration of the
thiol: L-cys, DTT, and ASB were 4 mM. Enzyme activity was determined
after 10, 30, 60 min of incubation; b Influence of thiol order of
components preincubation on urease inactivation by ASB. The
initial 20 min preincubation mixture contained components
given in brackets. The preincubation was continued the further
20 min after addition of the last component (component given
outside for brackets). The final preincubation mixtures contained
0.25 mg/mL urease, 20 mM phosphate buffer, pH 7.0, 2 mM
EDTA, 4 mM ASB, and DTT or L-cys. Enzyme activity was determined
after 40 min of preincubation time. The percent of the enzyme activity
in the presence of ASB without the thiol is given for comparison
Fig. 8 Reactivation of ASB-inactivated urease by L-cys or DTT. Activity
of urease inactivated by ASB (blue line) and after adding L-cys (yellow)
or DTT (purple). Urease was inactivated by 4 mM ASB, and 4 mM L-cys
or DTT was added into the reaction system 20 min later (as indicated
by the vertical arrow)
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By contrast, by multidilution, urease remained in con-
stant activity as the concentration of ammonia increased,
which indicated that an insignificant amount of the ac-
tive enzyme separated from urease-ASB complex after
dilution due to no further release of active urease (data
not shown). Taken together, there would be a supposed
reversibility between urease and ASB, in which the
chemical approach but not multidilution could recover
the enzyme activity that had been inactivated by ASB.
Molecular docking
In order to elucidate the inhibition mechanism revealed
by the kinetics study, molecular docking of ASB into the
crystal structure of JBU (3LA4 in the Protein Data bank)
was performed by the AutoDock program, and the best
possible binding modes were shown in Fig. 9.
In the best possible binding mode, ASB tightly an-
chored the helix-turn-helix motif over the active-site
cavity through O −H∙ ∙ ∙S, N −H∙ ∙ ∙O, and O −H∙ ∙ ∙O
hydrogen bonding interactions. This mode made ASB
engage a cleft beside the active-site cavity, using 3 typical
hydrogen bonds to anchor the flap tightly with the back-
bone of the enzyme, thereby preventing the flap from
backing to the close position. The 12- SO3H of ASB, as
the hydrogen bond donor ,was found between the OH
and the backbone S atom of CME 592 (H∙ ∙ ∙S distance =
2.7 Å), which was located on the mobile flap closing the
active site of the enzyme. In addition, the 12- SO3H of
ASB was bound via two hydrogen bonds to NH2 of ARG
439 with O∙∙∙H distance of 2.7 Å and 2.8 Å, respectively.
The Cys-592 (marked as CME592) is a key residue lo-
cated at the mobile flap covering the active site, one per
each of the six sites in the hexameric molecule [38]. Be-
sides being directly involved in the architecture of the
active site, the residue has a vital role in positioning
other key residues in the active site appropriately for the
catalysis [28, 39]. The flexible flap goes through an
open-closed-open procedure, effectively activating the
inert urea leading to activated enzyme during the normal
urea catalyzed by urease [40]. And modification of Cys-
592 resulted in restriction of the mobility of the flap,
subsequently perturbed the reaction, and reduced en-
zymatic activity. In addition, ARG-439, the other residue
of the flap at the entrance of the binding pocket, partici-
pate in the substrate binding, stabilize the catalytic tran-
sition state, and accelerate the reaction mainly through
hydrogen bonding. It was reported that some urease in-
hibitors depressed JBU activities by interacting with the
sulfhydryl group of residues, especially the Cys-592 [41].
As the results described, ASB possibly made hydrogen
bonding interactions with the side chains of the above-
mentioned residues, especially the active-site flap Cys-
592, hence preserving the flap in an open conformation
and resulting in an inactivation. The observation was
soundly supportive of the earlier conclusion drawn from
the urease protection experiments performed with the
active-site binding inhibitors, which supported the ob-
servation that inhibition by ASB involved the participa-
tion of sulfhydryl group of the active-site cysteine.
Taking into account the peculiarities of the active-site
flap cysteine in the urease catalysis and sulfhydryl group
in urease activity, it could be inferred that ASB made
contacts with the side chains of cysteine residues, espe-
cially sulfhydryl group, which was reflected in their en-
hanced affinity to the Cys-592. As a result, the mobility
of flap was restricted, and the enzymatic activity signifi-
cantly declined finally.
Conclusions
Based on the research on the mechanism and kinetics of
urease inhibition by ASB in the present study, it could
be concluded that ASB was a competitive inhibitor
targeting thiol groups in the active site of urease in a
slow-binding manner, both concentration dependent and
reversible. Hence, ASB deserves to be further exploited
as a promising urease inhibitor for treatments of urease-
related diseases.
Fig. 9 a Molecular docking simulations obtained at the lowest
energy conformation, highlighting potential hydrogen contacts of
ASB. For clarity, only interacting residues are labeled. Hydrogen
bonding interactions are shown by dashes; b Surface representation of
the active-site flap of JBU with ASB shown at the entrance of the
binding pocket. (colored by atom: carbon is yellow; oxygen is red;
hydrogen is white; sulfur is brown; nitrogen was blue)
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